The table below shows ANI PHARMACEUTICALS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$10.60M
$12.30M
$16.54M
$10.56M
$10.13M
$7.30M
SG&A
ANIP annual revenue (10-K history)
ANI PHARMACEUTICALS INC reported annual revenue of $883.37M for fiscal year 2025. That is up 43.8% from $614.38M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $128.62M (FY 2016) to $883.37M. Figures come from the company's audited annual reports as filed with the SEC.